Search

everythinglearnresearchcommunity

for

Search:↓

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Stopping minoxidil and draining fluid around the heart can save lives in rare cases.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Older women reported negative physical and psychological effects from Botox and facial fillers, feeling neglected by the medical system.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Various treatments exist for hair loss, but more research is needed for better options.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Biologics for severe asthma have known side effects, but some new risks need more study.

Hormonal contraceptives are effective for teens but require careful consideration of side effects and individual health.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

A boy with a rare birthmark called verrucous hemangioma needed careful timing for surgery due to its size and depth.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

New psoriasis treatments are effective but come with side effects and risks.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

JAK inhibitors show promise for treating various skin diseases.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Upadacitinib may effectively treat alopecia areata without side effects.

Oral propranolol successfully treated a baby's skin growth and ulceration linked to PELVIS syndrome.